MHRA explains that its emphasis will remain firmly on vetting when it comes to pharma advertising
An aspirational framework to make the most of data and its role in improving patient care
Is pharmacovigilance unnecessary policing or a strategic asset for pharma companies?
Despite regulation becoming more harmonised, SME expansion still presents complex access challenges
Medical progress, health expenditure, ageing populations and the future of our healthcare systems
A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – it's free to add your pharma/healthcare campaigns. Just contact us.
Aventis Pasteur MSD
Infections and Infestations
Icon Corporate Brand
Hanson Zandi Advertising Ltd
Infections and Infestations
More from the gallery
In recent years pharma has slowly been realising the importance of customer experience and the fact that the commercial model that served it so well for the past 30 years
Companies developing rare disease treatments face several unique challenges when it comes to regulatory and reimbursement submissions.
Doctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.
What does ‘authenticity’ mean to the healthcare sector and how can companies best build authentic relationships with their stakeholders?
NHS England's siloed budget and its uncertain
Obesity is on the rise in low- and middle-income countries, particularly in urban settings
The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge
Overcoming flaws in leadership development with pharma companies
Key skills and qualities for a career in medical writing
A good match produces the best results
Senior industry figures are taking an ‘ex-directory’ network
Cubist's Patrick Vink on the company's ambitions in anti-infectives
Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone
IBM's Amer Fasihi on the rise of Watson
GCI Health's Caroline Howley on who's winning the PR battle around the junior doctors' strike.
Everyone is under pressure to deliver results fast, so how can you speed up the positive effects of your e-detailing and multichannel communication? One proven answer is to get the
Pharma content marketing is still fairly new in the scheme of things for the pharma industry. In the conservative and traditional pharma industry that’s fraught with regulations, getting management buy-in
Asia-Pacific and Japan